Industry update tracker: September 2026
September 2026's round-up of company press releases and announcements shaping the real-world data (RWD), real-world evidence (RWE) and health technology assessment (HTA) landscape.
Atropos Health Scales Federated Evidence Network with Multimodal Data Partners to Accelerate Health Analytics and AI Model Development
Atropos Health, a leader in RWE generation from high-quality healthcare data, announced a significant expansion of its federated Atropos Evidence™ Network. The expansion includes deeper collaborations with Norstella and Arcadia, along with new data partnership agreements with OneMedNet Corporation. These alliances extend the scope of Atropos Health’s data ecosystem across clinical decision support (CDS), model training, and benchmark development, delivering precision insights to power modern medicine.
BC Platforms launches BC Mosaic App Store to empower Data Scientists And Healthcare Researchers with Innovative Analytics And Workflow Applications
BC Platforms announced the launch of the BC Mosaic App Store, a certified ecosystem of specialized analytical and research applications. Through the BC Mosaic App Store, research teams can discover and easily access certified applications and analytical capabilities that support healthcare research, precision medicine, clinical development, post-approval research, and real-world evidence.
King's College Hospital NHS Foundation Trust Joins Briya's Global Data Network, expanding evidence available through AIRE
Briya, the health AI technology company redefining healthcare research with a trusted AI assistant, announced a strategic partnership with King's College Hospital NHS Foundation Trust, one of the UK's largest and busiest teaching Trusts, to advance AI-native medical research through collaborative RWE initiatives. King's College Hospital NHS Foundation Trust provides specialist services to some of the most vibrant and diverse communities in the country, from inner city neighborhoods to suburban communities. This expands the depth and diversity of RWE available to researchers and life sciences organizations studying disease, treatment pathways, and patient outcomes at population scale.
Century Health and Eye Health America to Unlock a Decade of Real-World Data to Advance Chronic Retinal Disease Research
Century Health, a pioneer in applying AI to real-world clinical data to accelerate research, and Eye Health America (EHA), a leading integrated eye care platform in the Southeastern United States, announced a partnership to transform years of clinical data into research-grade datasets that support real-world evidence generation and life sciences research for chronic retinal conditions, including diabetic retinopathy and age-related macular degeneration (AMD).
Data4Life, Monash Health Partner to Accelerate Clinical Trials and Real-World Evidence Generation
Data4Life and Monash Health have partnered to optimize clinical trial design and execution, complemented by educational workshops and professional training programs, with a shared commitment to improving patient outcomes. Monash Health, the largest public health service in Victoria, Australia, will support the alliance's clinical trials through optimized trial timelines and patient enrolment, helping to achieve fast and effective subject recruitment. Data4Life will streamline clinical trial processes, collaborate on patient recruitment activities, and support the secondary use and standardisation of health data through open science and common data models, alongside professional training in Good Clinical Practice (GCP), study conduct, and other areas of clinical research.
Flatiron Health Expands Global Panoramic Datasets with AI-Powered Breast Cancer and NSCLC Real-World Data for the UK, Germany, and Japan
Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using RWD, announced the launch of breast cancer and non-small cell lung cancer (NSCLC) Panoramic datasets in the UK, Germany, and Japan. This marks the next phase of Flatiron's global evidence expansion, following the company's first multinational Panoramic data launch for prostate cancer in January 2026, to deliver longitudinal, AI-extracted RWD built on a common data model across geographies.
NCCN and Flatiron Health Announce Renewal of Collaboration to Advance Real-World Data Research Across Leading Cancer Centers
Flatiron Health also announced the renewal of its collaboration with the National Comprehensive Cancer Network® (NCCN®), an alliance of leading cancer centers devoted to patient care, research, and education. The agreement, which dates back to 2014, extends through 2028 and reaffirms Flatiron's commitment to supporting RWE research across the NCCN academic medical center network. As part of the renewal, Flatiron is expanding how NCCN Member Institutions engage with its data through access to Flatiron Telescope, which enables a broader range of users to conduct research and generate insights without requiring deep technical expertise.
Nested Knowledge and EviValue Announce Strategic Partnership to Advance AI-Enabled Evidence Synthesis, Healthcare Economic Modeling and Real-World Evidence
Nested Knowledge, a leading AI-enabled platform for systematic literature reviews and evidence synthesis, and EviValue, a healthcare research and technology organization specializing in evidence synthesis, health economics and outcomes research (HEOR), real-world evidence, economic modeling, commercial analytics, medical affairs consulting and market access, announced a strategic partnership to expand access to technology-enabled evidence synthesis and evidence-to-decision capabilities, with a particular focus on the Asia-Pacific region.
nference and Rush University System for Health Launch Long-Term Partnership to Advance AI-Enabled Clinical Research and Patient Care
Rush University System for Health (Rush) and nference, a company advancing agentic AI for biomedical discovery and healthcare superintelligence, today announced a long-term strategic collaboration to create a secure, Rush-hosted clinical analytics platform that will enable Rush researchers to more effectively analyze de-identified, longitudinal and multimodal clinical data. The agreement makes Rush University Medical Center the first Illinois-based academic medical center to partner with nference. The platform will help Rush researchers generate real-world evidence and accelerate clinical research, with the ultimate goal of translating insights into better care and outcomes for patients.
Norstella Launches Real-World Data Agentic Platform and First Agent to Replace Manual Cohort Building
Norstella, the global biopharma commercial intelligence and data company, launched its new agentic platform for RWD. The platform is built on Norstella’s curated, integrated RWD asset and centralized delivery system. With it, teams have full transparency: they can pull data on demand, track every request from status updates to SLAs, and explore other data modalities across NorstellaLinQ to enrich their cohorts.
Oracle and Buck Institute for Research on Aging Advance Landmark Federal Aging Research Initiative
Oracle and the Buck Institute for Research on Aging are collaborating to advance intelligence into age-related disease and support discoveries that can extend the healthy years of life. Buck will leverage Oracle Life Sciences Data Intelligence, which encompasses 122 million+ de-identified longitudinal Oracle Health Real-World Data records and advanced analytics to research biomarkers that aim to enable early detection and targeted intervention for aging-related complications. The research will also be used to pursue qualification for the first FDA-grade "Intrinsic Capacity Score," a vitality score for healthy aging.
PurpleLab Launches CARES: A New Center for Advancing Real-World Evidence Studies
PurpleLab®, the leading healthcare data analytics company, announced the launch of the PurpleLab Center for Advancing Real-World Evidence Studies (PurpleLab CARES), an initiative designed to promote the use of PurpleLab’s RWD for research studies, facilitate academic partnerships, and support patient advocacy efforts.
Sikka Insights Launches Galaxy: De-Identified Real-World Healthcare Data, and a Calibrated Environment to Train Agents
Sikka Insights, Inc. launched Galaxy, offering de-identified retail healthcare data to AI laboratories via two products: Galaxy Corpora, for direct data licensing, and Galaxy Environments, a hosted platform where AI agents interact with practice management interfaces with outcomes calibrated on two decades of observed healthcare data. The underlying corpus has been accumulating inside working medical practices for over 20 years and has not previously been offered to the AI research market. It comprises 1.4 billion classified files across approximately 1.5 petabytes, including 887 million de-identified dental radiographs, 192 million patient records across 46,000 dental and orthodontic practices, 65 million operational and clinical documents, and 43 million animal patient records across 2100 veterinary practices with 1.3 billion procedure records.
Truven Launches MarketScan Snapshot, an AI-powered Tool to Evaluate Fit-For-Purpose Real-World Data in Minutes
Truven, a trusted leader in healthcare data and analytics, launched MarketScan Snapshot, an AI-powered capability that gives users a faster, more intuitive way to assess whether MarketScan RWD will support their analytics needs. MarketScan Snapshot helps users rapidly explore patient populations and data availability within the MarketScan Research Databases, supporting faster feasibility assessment and more confident evidence planning.
Verana Health Introduces New AI Agents to Expedite and Streamline R&D
Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through RWD, has announced the release of new AI agents to aid researchers. Agent Claire for Life Sciences, available in disease-specific versions, enables researchers to rapidly generate analytic insights. Researchers can query the rich real-world datasets using conversational questions that range in sophistication. Leveraging specialized clinical training, the agent formulates execution plans and evaluates them against embedded clinical guardrails. With Agent Claire for Life Sciences, researchers have immediate, direct access to extensive data, without needing programming skills or analyst assistance.
| Register for free today to become a member of The Evidence Base and receive the latest news straight to your inbox. |